Lonza is to sell off two European sites to NextPharma in a deal that gives the contract development and manufacturing firm facilities to work with lipid oral dosage forms for the nutrition and pharma markets.
British pharma company GlaxoSmithKline (GSK) are to pair up with Eligo Bioscience in a deal potentially worth €185m ($224m) that sees the firms target the microbiome to reduce the risk of developing acne.
In response to the pandemic, UK firm Westomatic has made available a new contactless drinks dispenser that can mix up and distribute protein shakes along with a number of sports nutrition-based beverages.
Winclove Probiotics reveals details of a new platform designed to fast-track the probiotic product development cycle, which they say will generate €8m in turnover in the first five years of commercialisation.
So-called 'transition' or toddler formulas allegedly trick parents into thinking these products adhere to the same standards as infant formula, according to three separate but nearly identical class action lawsuits.